Skip to main content
. Author manuscript; available in PMC: 2018 Jan 5.
Published in final edited form as: Appl Physiol Nutr Metab. 2017 Jun 23;42(10):1092–1096. doi: 10.1139/apnm-2017-0292

Table 1.

Demographics for short interpregnancy interval participants and controls

Characteristic SIPI (n=26)
n(%)
Controls (n=52)
n(%)
Total (n=78)
n(%)
Ethnicity
 European 21 (81) 42 (81) 63 (81)
 Asian 1 (4) 1 (2) 2 (3)
 Mixed 0 (0) 0 (0) 0 (0)
 Unknown 4 (15) 8 (15) 12 (15)
Marital status
 Single 0 (0) 3 (6) 3 (4)
 Married/living with/partnered 26 (100) 49 (94) 75 (96)
Highest education level
 Completed high school 25 (96) 32 (61) 57 (73)
 Some post-secondary 24 (92) 11 (21) 35 (45)
Income
 <$20, 000 4 (15) 0 (0) 4 (5)
 $20, 000 – $40, 000 4 (15) 7 (13) 11 (14)
 $41, 000 – $60, 000 5 (20) 4 (8) 9 (12)
 $61, 000 – $80, 000 4 (15) 13 (25) 17 (22)
 $81, 000 – $100, 000 6 (23) 6 (12) 12 (15)
 >$100, 000 3 (12) 11 (21) 14 (18)
Psychiatric history
 Major depressive disorder 18 (69) 43 (83) 61 (78)
 Bipolar disorder 8 (31) 8 (15) 16 (21)
 Taking psychotropic medication2 2 (8) 4 (8) 6 (12)
Number of Children Prior to Index Pregnancy
 0 0 (0) 36 (70) 36 (46)
 1 25 (96) 13 (25) 38 (49)
 2 0 (0) 2 (4) 2 (3)
 3 1 (4) 1 (2) 2 (3)
2

Psychotropic medication that participants were taking, that could interfere with folate metabolism, include citalopram, epival, lorazepam, paroxetine, sertraline, topamax (Lambie and Johnson 1985; Linnebank et al. 2011)